Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Amorfix Life Sciences Ltd

+ Add to Watchlist

AMF:CN

0.0450 CAD 0.0100 18.18%

As of 15:30:05 ET on 04/27/2015.

Snapshot for Amorfix Life Sciences Ltd (AMF)

Open: 0.0500 Day's Range: 0.0450 - 0.0500 Volume: 71,500
Previous Close: 0.0550 52wk Range: 0.0250 - 0.3800 1-Yr Rtn: -86.96%

Stock Chart for AMF

No chart data available.
  • AMF:CN 0.0450
  • 1D
  • 1M
  • 1Y
0.0550
Interactive AMF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMF

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPTSX -
Earnings Per Share (ttm) -0.0372
Est. EPS -
Est. PEG Ratio -
Market Cap (M CAD) 3.11
Shares Outstanding (M) 69.07
30 Day Average Volume 252,901
Price/Book (mrq) -
Price/Sale (ttm) 8.7011
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMF

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMF

Amorfix Life Sciences Ltd. is a product development company which focuses on therapeutic products and diagnostics targeting misfolded protein diseases including ALS, cancer, and Alzheimer's disease. The Company uses their discovery platform to detect disease specific epitopes on the molecular surface and develops antibodies for diagnostic and clinical evaluation.

Warren WhiteheadChief Financial OfficerRobert M GundelPresident/CEO
Neil CashmanChief Scientific Officer/Co-Founder
More Company Profile & Key Executives for AMF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil